days ago, the founding conference of Ruipu Biological Industry College (hereinafter referred to as Ruipu Biological Industry College) of Tianjin Vocational University was grandly held at Ruipu Biological Headquarters. It opened a new chapter in Tianjin Vocational University to help Bincheng's bio-pharmaceutical industry develop, and schools and enterprises collaborate in educating people, achieving win-win results.
(Site of the establishment ceremony of Ruipu Biological Industry College)
(Speech by Shen Jiang, Secretary of the Party Committee of Tianjin Vocational University)
At the establishment ceremony, Shen Jiang, Secretary of the Party Committee of Tianjin Vocational University, said that Ruipu Biological is the largest manufacturer and service provider of animal health products in my country, integrating biological vaccines, drug raw materials, drug preparations, and feed additives in one. The School of Biological and Environmental Engineering of Tianjin Vocational University is the oldest college in the school. The major of the pharmaceutical production technology is dedicated to serving the technology upgrade of high-end biomedicine industries and small and medium-sized enterprises. Through precise docking, complementary advantages, and joint consultation and construction, the two sides will surely integrate into regional development and promote industrial upgrading, and contribute to the dream of vocational education with great potential.
(Speech by Tong Yue, Vice President of Ruipu Biotechnology Co., Ltd.)
Vice President of Tianjin Ruipu Biotechnology Co., Ltd. Tong Yue said that the school actively serves the talent needs of the biomedical industry, and has achieved remarkable achievements in curriculum resource development, talent training and faculty team building, and is highly complementary to the enterprise. The establishment of Ruipu Biological Industry College through the cooperation between schools and enterprises can fully integrate the high-quality resources of both parties, closely focus on the needs of the pharmaceutical industry, and cultivate future pharmaceutical production talents.
(Inauguration ceremony of Tianjin Vocational University Rip Biological Industry College)
As a technology research and development enterprise deeply rooted in the energy and insurance industry, Rip Bio's annual R&D funding in the bonded area has exceeded 150 million yuan, and the R&D team exceeds 400 people. At present, in addition to full suspension technology, Rip Bio also has a genetically engineered vaccine technology platform to develop the world's first avian influenza DNA vaccine, making my country the second country after the United States to master the third-generation vaccine technology, which is of great significance to my country's transformation from a world vaccine power to a vaccine power.
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-